Press Release

Updates and news NEWS One of SHIFTBIO's leading program has been accepted for publication in Nature Communications

Updates and news NEWS SHIFTBIO is sending warm wishes to everyone for a Merry Christmas and a Happy New Year

Updates and news NEWS SHIFTBIO INC Awarded as an Outstanding "Global Collaboration Company"

Updates and news NEWS SHIFTBIO INC. was honored to participate in the Exosome-Based Therapeutic Development Summit held in Boston

Updates and news NEWS SHIFTBIO INC. has invited to the 'Korea Conference 2024' for the third consecutive year

Updates and news NEWS SHIFTBIO INC. is delighted to share the preprint of our second program, HIF1α-NNP

Updates and news NEWS SHIFTBIO INC. was honored as the Top Poster at the 'EASL Congress 2024'

Updates and news NEWS Gi-Hoon Nam, CEO of SHIFTBIO INC., Featured Speaker at ISCT 2024 in Vancouver

Updates and news NEWS Dr. Dolores Di Vizio, a world-class scientist in circulating extracellular vesicles, has joined SHIFTBIO INC’s Scientific Advisory Board (SAB)

Updates and news NEWS SHIFTBIO INC. is delighted to share the preprint of our lead program, SIRP-NNP

Updates and news NEWS SHIFTBIO INC. Participates in the '2024 EV Characterization & Analytic Development Summit' in Boston, MA

Updates and news NEWS SHIFTBIO INC. has participated in the ‘Biocom Global Partnering' event

Updates and news NEWS SHIFTBIO INC. were invited to the “Korea-Germany Innovation Partnership Forum" in Berlin, Germany

Updates and news NEWS SHIFTBIO's SIRP-EV achieved an Orphan Drug Designation(ODD) for Acute Liver Failure from FDA

Updates and news NEWS SHIFTBIO INC. attended the 'Biotech Showcase 2024' in San Francisco

Updates and news NEWS SHIFTBIO INC. received Global Business Award at the ‘Hongneung Start-up Conference'

Updates and news NEWS In-San Kim, a core founder of SHIFTBIO INC, recently highlighted the potential of exosomes.

Updates and news NEWS Merry Christmas and a Happy New Year from SHIFTBIO!

Updates and news NEWS SHIFTBIO INC. has received "Ministry of SMEs and Startup Business Award"

Updates and news NEWS Dr. In-San Kim, a co-founder of SHIFTBIO INC., has been invited as a speaker to the ANSEV 2023 Conference

Updates and news NEWS Dr. Gi-Hoon Nam joined as a speaker at two of the largest startup events in the country

Updates and news NEWS SHIFTBIO INC. is thrilled to join the Seoul-Basel Start-up program this November!

Updates and news NEWS Dr. Gi-Hoon Nam, CEO of SHIFTBIO INC.: Invited as a speaker at the '2023 Biopharma Open Innovation'.

Updates and news NEWS Dr. Gi-Hoon Nam joined as a speaker at 'The 24th World Knowledge Forum'

Updates and news NEWS Dr. Gi-Hoon Nam, CEO of SHIFTBIO: Joined two consecutive years as speaker at 'The 5th Exosome Based Therapeutic Development Summit' in Boston

Updates and news NEWS [Triumphant Success at Korea Conference] A Star Wars of Startups

Updates and news NEWS SHIFTBIO INC. has initiated a joint research collaboration with the global enterprise Dassault Systems on an “AI-driven Cell-Free Nanotherapy Platform Technology.”